SP Elixir (OPC) Private Limited

Mycofit 500mg (Mycophenolate Mofetil) Tablets IP is an immunosuppressive medication used primarily to prevent organ rejection in kidney, heart, and liver transplant recipients. It is also used to treat certain autoimmune diseases, such as lupus nephritis (a kidney complication of lupus) and rheumatoid arthritis.

Mycophenolate mofetil works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH), which plays a key role in the production of purines, the building blocks of DNA. By blocking this enzyme, Mycofit suppresses the activity of T and B lymphocytes, cells of the immune system that contribute to rejection or inflammation in autoimmune diseases.

The tablets are typically taken orally, and the dosage may vary based on the specific condition being treated. For transplant patients, it is often used in combination with other immunosuppressive drugs to achieve optimal results.

Common side effects include gastrointestinal symptoms like nausea, vomiting, diarrhea, and abdominal pain. Long-term use can also increase the risk of infections and certain types of cancer due to its immune-suppressing effects. Blood cell counts and liver function should be regularly monitored during treatment.

It is crucial to take Mycofit exactly as prescribed and to follow up with regular medical check-ups to monitor potential side effects.